Table 3.

Univariate and multivariate analysis of progression-free prognostic factors in patients with type II ovarian carcinomas.

Factors	Patients	Univariate			Multivariate
		hazard ratio	95% CI	p-value	hazard ratio	95% CI	p-value
FIGO stage
I, II	31	7.1	2.1–24.1	0.0015	1.3	0.3–5.8	0.7511
III, IV	37
Age (years)
<60	32	2.5	1.0–6.0	0.0499	2.8	1.0–7.7	0.0438
≥60	36
Residual tumor
<1 cm	39	14.2	4.1–48.2	<0.0001	10.2	2.2–46.7	0.0028
≥1 cm	29
MAPK1 FISH
Amplification	5	4.4	1.4–1.3	0.0098	4.2	1.2–15.0	0.0285
Normal	63